Zinc Completed Phase 1 Trials for Major Depressive Disorder (MDD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02476058A Safety, Efficacy and Biomarker Study of JNJ-42847922 in Participants With Major Depressive Disorder